Selected research
Industry Research
Epimedium Capsules Industry Research Report 2026
Market perspective
The global Epimedium Capsules market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Epimedium Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Epimedium Capsules is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Epimedium Capsules is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Epimedium Capsules include GNC, Penn Herb, Shiseido, BIOHIGH, Bayer, Chenguang Biotech Group, Hunan Huabaotong Pharmaceutical, Liancun and MDE, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Epimedium Capsules market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Epimedium Capsules Market by Company
GNC
Penn Herb
Shiseido
BIOHIGH
Bayer
Chenguang Biotech Group
Hunan Huabaotong Pharmaceutical
Liancun
MDE
Sirio Pharma
Innovation
Xiuzheng Group
Epimedium Capsules Segment by Type
60 Capsules/bottle
100 Capsules/bottle
Others
Epimedium Capsules Segment by Application
Online Sales
Offline Sales
Epimedium Capsules Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Epimedium Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Epimedium Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Epimedium Capsules.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Epimedium Capsules manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Epimedium Capsules by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Epimedium Capsules in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 60 Capsules/bottle
- 100 Capsules/bottle
- Others
Applications
- Online Sales
- Offline Sales
Companies covered
- GNC
- Penn Herb
- Shiseido
- BIOHIGH
- Bayer
- Chenguang Biotech Group
- Hunan Huabaotong Pharmaceutical
- Liancun
- MDE
- Sirio Pharma
- Innovation
- Xiuzheng Group
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Epimedium Capsules Market Size (2021-2032)
- 2.2.2 Global Epimedium Capsules Sales (2021-2032)
- 2.2.3 Global Epimedium Capsules Market Average Price (2021-2032)
- 2.3 Epimedium Capsules by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 60 Capsules/bottle
- 2.3.3 100 Capsules/bottle
- 2.3.4 Others
- 2.4 Epimedium Capsules by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Online Sales
- 2.4.3 Offline Sales
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Epimedium Capsules Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Epimedium Capsules Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Epimedium Capsules Revenue of Manufacturers (2021-2026)
- 3.4 Global Epimedium Capsules Average Price by Manufacturers (2021-2026)
- 3.5 Global Epimedium Capsules Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Epimedium Capsules, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Epimedium Capsules, Product Type & Application
- 3.8 Global Manufacturers of Epimedium Capsules, Established Date
- 3.9 Global Epimedium Capsules Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 GNC
- 4.1.1 GNC Company Information
- 4.1.2 GNC Business Overview
- 4.1.3 GNC Epimedium Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 GNC Epimedium Capsules Product Portfolio
- 4.1.5 GNC Recent Developments
- 4.2 Penn Herb
- 4.2.1 Penn Herb Company Information
- 4.2.2 Penn Herb Business Overview
- 4.2.3 Penn Herb Epimedium Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Penn Herb Epimedium Capsules Product Portfolio
- 4.2.5 Penn Herb Recent Developments
- 4.3 Shiseido
- 4.3.1 Shiseido Company Information
- 4.3.2 Shiseido Business Overview
- 4.3.3 Shiseido Epimedium Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Shiseido Epimedium Capsules Product Portfolio
- 4.3.5 Shiseido Recent Developments
- 4.4 BIOHIGH
- 4.4.1 BIOHIGH Company Information
- 4.4.2 BIOHIGH Business Overview
- 4.4.3 BIOHIGH Epimedium Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 BIOHIGH Epimedium Capsules Product Portfolio
- 4.4.5 BIOHIGH Recent Developments
- 4.5 Bayer
- 4.5.1 Bayer Company Information
- 4.5.2 Bayer Business Overview
- 4.5.3 Bayer Epimedium Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Bayer Epimedium Capsules Product Portfolio
- 4.5.5 Bayer Recent Developments
- 4.6 Chenguang Biotech Group
- 4.6.1 Chenguang Biotech Group Company Information
- 4.6.2 Chenguang Biotech Group Business Overview
- 4.6.3 Chenguang Biotech Group Epimedium Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Chenguang Biotech Group Epimedium Capsules Product Portfolio
- 4.6.5 Chenguang Biotech Group Recent Developments
- 4.7 Hunan Huabaotong Pharmaceutical
- 4.7.1 Hunan Huabaotong Pharmaceutical Company Information
- 4.7.2 Hunan Huabaotong Pharmaceutical Business Overview
- 4.7.3 Hunan Huabaotong Pharmaceutical Epimedium Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Hunan Huabaotong Pharmaceutical Epimedium Capsules Product Portfolio
- 4.7.5 Hunan Huabaotong Pharmaceutical Recent Developments
- 4.8 Liancun
- 4.8.1 Liancun Company Information
- 4.8.2 Liancun Business Overview
- 4.8.3 Liancun Epimedium Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Liancun Epimedium Capsules Product Portfolio
- 4.8.5 Liancun Recent Developments
- 4.9 MDE
- 4.9.1 MDE Company Information
- 4.9.2 MDE Business Overview
- 4.9.3 MDE Epimedium Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 MDE Epimedium Capsules Product Portfolio
- 4.9.5 MDE Recent Developments
- 4.10 Sirio Pharma
- 4.10.1 Sirio Pharma Company Information
- 4.10.2 Sirio Pharma Business Overview
- 4.10.3 Sirio Pharma Epimedium Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Sirio Pharma Epimedium Capsules Product Portfolio
- 4.10.5 Sirio Pharma Recent Developments
- 4.11 Innovation
- 4.11.1 Innovation Company Information
- 4.11.2 Innovation Business Overview
- 4.11.3 Innovation Epimedium Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Innovation Epimedium Capsules Product Portfolio
- 4.11.5 Innovation Recent Developments
- 4.12 Xiuzheng Group
- 4.12.1 Xiuzheng Group Company Information
- 4.12.2 Xiuzheng Group Business Overview
- 4.12.3 Xiuzheng Group Epimedium Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Xiuzheng Group Epimedium Capsules Product Portfolio
- 4.12.5 Xiuzheng Group Recent Developments
5 Global Epimedium Capsules Market Scenario by Region
- 5.1 Global Epimedium Capsules Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Epimedium Capsules Sales by Region: 2021-2032
- 5.2.1 Global Epimedium Capsules Sales by Region: 2021-2026
- 5.2.2 Global Epimedium Capsules Sales by Region: 2027-2032
- 5.3 Global Epimedium Capsules Revenue by Region: 2021-2032
- 5.3.1 Global Epimedium Capsules Revenue by Region: 2021-2026
- 5.3.2 Global Epimedium Capsules Revenue by Region: 2027-2032
- 5.4 North America Epimedium Capsules Market Facts & Figures by Country
- 5.4.1 North America Epimedium Capsules Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Epimedium Capsules Sales by Country (2021-2032)
- 5.4.3 North America Epimedium Capsules Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Epimedium Capsules Market Facts & Figures by Country
- 5.5.1 Europe Epimedium Capsules Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Epimedium Capsules Sales by Country (2021-2032)
- 5.5.3 Europe Epimedium Capsules Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Epimedium Capsules Market Facts & Figures by Country
- 5.6.1 Asia Pacific Epimedium Capsules Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Epimedium Capsules Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Epimedium Capsules Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Epimedium Capsules Market Facts & Figures by Country
- 5.7.1 South America Epimedium Capsules Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Epimedium Capsules Sales by Country (2021-2032)
- 5.7.3 South America Epimedium Capsules Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Epimedium Capsules Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Epimedium Capsules Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Epimedium Capsules Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Epimedium Capsules Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Epimedium Capsules Sales by Type (2021-2032)
- 6.1.1 Global Epimedium Capsules Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Epimedium Capsules Sales Market Share by Type (2021-2032)
- 6.2 Global Epimedium Capsules Revenue by Type (2021-2032)
- 6.2.1 Global Epimedium Capsules Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Epimedium Capsules Revenue Market Share by Type (2021-2032)
- 6.3 Global Epimedium Capsules Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Epimedium Capsules Sales by Application (2021-2032)
- 7.1.1 Global Epimedium Capsules Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Epimedium Capsules Sales Market Share by Application (2021-2032)
- 7.2 Global Epimedium Capsules Revenue by Application (2021-2032)
- 7.2.1 Global Epimedium Capsules Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Epimedium Capsules Revenue Market Share by Application (2021-2032)
- 7.3 Global Epimedium Capsules Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Epimedium Capsules Value Chain Analysis
- 8.1.1 Epimedium Capsules Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Epimedium Capsules Production Mode & Process
- 8.2 Epimedium Capsules Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Epimedium Capsules Distributors
- 8.2.3 Epimedium Capsules Customers
9 Global Epimedium Capsules Analyzing Market Dynamics
- 9.1 Epimedium Capsules Industry Trends
- 9.2 Epimedium Capsules Industry Drivers
- 9.3 Epimedium Capsules Industry Opportunities and Challenges
- 9.4 Epimedium Capsules Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst